HomeSLS • NASDAQ
Follow
Sellas Life Sciences Group Inc
Previous close
$1.03
Day range
$0.99 - $1.03
Year range
$0.50 - $1.91
Market cap
55.70M USD
Avg Volume
1.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.36M | 31.00% |
Net income | -9.27M | -31.97% |
Net profit margin | — | — |
Earnings per share | -0.33 | 2.94% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.97M | -81.41% |
Total assets | 8.09M | -68.90% |
Total liabilities | 11.91M | -11.12% |
Total equity | -3.83M | — |
Shares outstanding | 32.06M | — |
Price to book | -7.92 | — |
Return on assets | -175.62% | — |
Return on capital | -1,942.92% | — |
Cash Flow
Net change in cash
(USD) | Sep 2023info | Y/Y change |
---|---|---|
Net income | -9.27M | -31.97% |
Cash from operations | -6.89M | -19.94% |
Cash from investing | -3.00M | — |
Cash from financing | 54.00K | -49.53% |
Net change in cash | -9.84M | -74.46% |
Free cash flow | -9.47M | -199.17% |
About
Founded
2006
Website
Employees
17